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ABSTRACT 
According to existing literature, there is a suggested correlation between certain 
vaccinations and oral cavity symptoms. Studies have shown that the Diphtheria, Tetanus, 
Acellular Pertusis, as well as Polio Vaccinations have an association with presented symptoms of 
bleeding gums, sores, ulcers, white spots in the mouth or on lips, and unpleasant breath odor. 
Although these symptoms may not occur simultaneously or directly after administration of the 
immunization, there has been supported evidence of correlation. Given the relevance of an 
association between vaccinations and orally manifested side effects, an investigation on the 
presence of such association with the widely administered flu vaccine was conducted. Data for 
this work was collected from a population including undergraduate students studying at the 
University of Central Florida. A brief voluntary online survey requesting demographic 
information regarding administration of the vaccine as well as any experienced side effects was 
used. The study was cohort in nature as it tracked subjects with known exposure to the flu shot in 
the past six months to understand the outcome of interest. Results from the survey were used to 
determine that there is no correlation between orally manifested side effects and administration 
of the flu vaccine. 
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CHAPTER ONE: INTRODUCTION 
As known from existing literature, there is a suggested correlation between certain 
vaccinations and symptoms manifested in the oral cavity.  Studies have shown that the 
Diphtheria, Tetanus, Acellular Pertusis, as well as Polio Vaccinations have an association with 
presented symptoms of bleeding gums, sores, ulcers, white spots in the mouth or on lips, 
unpleasant breath odor, among others that are on the more serious end of the spectrum.  Given 
the relevance of an association between vaccinations and orally manifested side effects, an 
investigation on the presence of such association with the widely administered flu vaccine should 
be conducted. There is no present research proving or otherwise refuting the existence of a 
correlation thus creating a gap in current knowledge.  
The purpose of this research project is to provide understanding of the way in which 
vaccines negatively affect the oral cavity. The following research seeks to investigate the 
correlation between the flu vaccine and any side effects manifested in the oral cavity.  The 
research question that is to be tested is “To what extent does the flu vaccine impact the oral 
cavity?” The purpose of this study is to characterize and assess the occurrence of symptoms 
commonly associated with periodontal disease and dental carries.  The results of this research 
project will highlight additional information for future elimination of the side effects resulting 
from the administration of the flu vaccine. 
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CHAPTER TWO: LITERATURE REVIEW 
 In a world where preventive health care is favored as opposed to disease treatment, 
vaccination has become a key factor in the medical society.  A vaccine is a biological preparation 
that provides active acquired immunity to a particular disease [2].  Vaccines typically contain an 
agent resembling the disease-causing organism made from weakened or killed forms of the 
microbe, its toxins, or surface proteins.  The mechanism by which it works is through tricking 
the body into believing that it is experiencing a full-scale invasion by an infectious agent, thus 
stimulating the body’s immune system to respond and destroy the microorganism by producing 
T-lymphocytes and antibodies [2].  This primary exposure leaves the body with memory immune 
cells- T-lymphocytes and B-lymphocytes that are to recognize and destroy antigens associated 
with the disease if ever in contact with it in the future.  
History of Vaccination 
 The idea of acquired immunity as a result of preliminary exposure was first introduced in 
the sixteenth century by the Chinese who practiced variolation or inoculation; where material 
was taken from a person infected with smallpox and “given artificially” through rubbing into 
superficial scratches made in the skin, which prevented people from developing scarring from 
natural smallpox [1].  In the late 1700s came the “founder of vaccinology,” Edward Jenner who 
created the world’s first vaccine against smallpox using the protective effect of cowpox. This is 
where the term vaccine or vaccination was derived from “Variolae Vaccinae,” which is Latin for 
smallpox of the cow [1].  Later in the nineteenth century was the birth of vaccines that are made 
in the laboratory.  French scientist Louis Pasteur “found means of attenuating” live organisms 
		
3	
including cholera and anthrax creating a breakthrough in the Germ Theory of Diseases [1].  
Progress continued into the production of vaccines that are used in modern day preventive 
medicine using several methods as live attenuation, killing of whole organisms, and purification 
of proteins of organisms or polysaccharides.  
The Age of Preventive Healthcare 
 There are currently 25 diseases that can be prevented to a great extent by a vaccination.  
Those are: Adenovirus, Anthrax, Diphtheria, Hepatitis A, Hepatitis B, Haemophilus influenzae 
type b (Hib), Human Papillomavirus (HPV), Seasonal Influenza (flu), Japanese Encephalitis, 
Measles, Meningococcal, Mumps, Pertussis, Pneumococcal, Polio, Rabies, Rotavirus, Rubella, 
Shingles, Smallpox, Tetanus, Tuberculosis, Typhoid Fever, Varicella, and Yellow Fever [6].  Of 
these diseases, two have been completely eradicated by their preventable vaccines; polio and 
smallpox [3].  Many of them are on the verge of eradication, including measles and pertussis 
(whooping cough).  Based on the US Centers for Disease Control and Prevention (CDC) 
recommended childhood vaccine schedule, a person will have received 69 doses of 16 vaccines 
by age 18. 
The Influenza Vaccine 
 Influenza, commonly known as the flu, is a contagious respiratory illness that is caused 
by the influenza virus and infects the nose, throat, and sometimes the lungs.  Seasonal influenza 
epidemics lasting from October to May cause serious and widespread illnesses each year.  
Disease resulting from the influenza virus affects all age groups but rates of infection are highest 
in high-risk groups, which are children under five and the elderly over 65 years [4].  The average 
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annual influenza-associated death rate from respiratory and circulatory causes between 1976 and 
2007 ranged from 3000 to 49 000.  The annual influenza vaccination has been proven to be the 
most effective strategy for the prevention of the seasonal influenza and its complications [9]. 
New strains of the vaccine are created with each annual flu season to accommodate for immunity 
developed by the virus and assure greatest protection from the disease.  The most commonly 
reported side effects to the influenza vaccine have been flu-like symptoms such as fever, 
soreness, and runny nose [9]. 
Vaccines as a Double-Edged Sword 
 With the great benefits presented by vaccination and their ability to prevent severe 
diseases, still comes incidences of minor, and in some rare instances, serious side effects as a 
result of vaccine administration.  That being said, many vaccine side effects can be 
asymptomatic or in some cases only present as generic cold like symptoms including headaches, 
fever, or an inflammation of some sort.  However, many side effects are manifested in the oral 
cavity, which includes components of the mouth as the lips, mucosal lining (gums), tongue, and 
teeth.  This is due to the fact that “immune-mediated diseases frequently affect oral mucosa,” 
often making the oral cavity “the first site of clinical manifestations” [15].  Moreover, many 
systemic conditions affect the mouth.  The accessibility of the oral cavity for examination allows 
for early and convenient detection of disorders, such as organ damage or inflammation, that are 
potentially caused as a result of vaccine administration [10].  The severity of the manifestations 
can be reflective of the severity of the disease and can therefore by used “as a tool for 
determining disease progression” and effective treatment plans [10]. 
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Vaccines and the Oral Cavity 
 According to existing literature, there is a suggested correlation between certain 
vaccinations and symptoms manifested in the oral cavity.  Studies have shown that presented 
symptoms of bleeding gums, sores, ulcers, white spots in the mouth or on the lips, and 
unpleasant breath odor were manifested after administration of some vaccines including 
diphtheria, tetanus, acellular pertussis, and polio vaccinations.  Although these symptoms may 
not occur simultaneously or directly after administration of the vaccination, there has been 
supported evidence of a correlation [9].  There have also been reports of adverse side effects 
manifested in the oral cavity associated with vaccine administration.  From 1991 until 1998, it 
has been known of 18 cases of Lichen Planus in France and Italy [7].  Lichen planus is an 
inflammation of the skin and mucosal membranes including those inside the mouth.  The 
incidences of occurrence have been reported to take place 7-120 days after vaccination against 
the Hepatitis B Virus (HBV) [7].  The vaccine may have simply “stimulated the immune system 
nonspecifically triggering lichen planus eruption” as occurs with other immune-related disorders 
[7].  Moreover, one case of a 41-year-old Hispanic male developing pemphigus vulgaris, an 
autoimmune blistering disorder of the skin and mucous membranes, was reported after the 
administration of the vaccination of the human papillomavirus [12].  Furthermore, a case of a 19-
month-old child developing pityriasus rubra pilaris, an erythemato-squamous disease of diffuse 
plaques with pityriasiform scales, has been reported two weeks following intramuscular 
diphtheria-tetanus-pertussis booster and oral poliovirus vaccination [13].  Another case finding is 
that of a 60-year-old male who presented with cutaneous verruca vulgaris lesions (warts) on the 
lips, tongues, and buccal mucosa after receiving the human papillomavirus vaccine [14].  Eight 
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other cases have been reported with similar warts and squamous cell papillomas, which are 
lesions caused by quadrivalent HPV vaccination [14]. 
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CHAPTER THREE: METHODOLOGY 
Study Design and Data Collection 
A cohort descriptive correlational study design will be utilized.  The targeted population 
from which the data for this study will be collected is undergraduate students studying at the 
University of Central Florida.  This will take place through sampling a randomized group of 
students in the approximately 60,000 student campus.  All subjects have to be 18 years of age or 
older to be eligible to participate in the study.   
A brief voluntary online survey will be used to collect information in order to determine 
the presence of trends following the administration of the flu vaccine.  An online survey will be 
created via the UCF Qualtrics account. The goal of the survey is to determine the presence of a 
correlation between the flu vaccine and any orally manifested side effects. The survey will 
consist of 14 questions including multiple choice as well as short response questions.  The survey 
will begin with a preliminary question asking for the participants consent to take part in the 
following survey.  Lack of consent will result in the termination of the survey and ineligibility of 
the study.  It will then be followed by demographic questions to determine the participants age 
and gender. Academic information will also be collected to determine the participants’ academic 
year in college and major. The following section will address receiving the flu vaccine and any 
experienced side effects, whether orally related or flu-like, as well as severity and duration of 
persistence of the symptoms, and if any medical attention was seeked. The survey is divided into 
different sections and shows one question at a time. An answer of “NO” on any of the questions 
exits the participant out of the survey and thanks them for their participation.  
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The voluntary online survey will be distributed via online collaborative websites through 
posting of announcements on different UCF affiliated pages on Facebook as well as in the 
classes taught by the principal investigator on the Webcourses page of the course.  This will 
ensure a randomized sample.  The survey will be open for respondents to complete for six weeks 
from when it is released.  Compensation to take part in the survey will not be provided. 
Participation for the duration of the survey, which is estimated to take a maximum of 15 minutes 
to complete, is merely voluntary and only according to the will of those in the targeted 
population.  All the surveys submitted will be completed anonymously with no identifying data 
collected.  The online survey presents no risk to the participants involved in completing it and 
subjects have the ability to withdraw at any time; however, only fully completed surveys will be 
used in the analysis process. 
Data Analysis 
Survey completion will be open to all students, however, only students who had received 
the flu shot in the past six months will be included in data analysis. The data will include 
information on the frequency of side effects resulting in proximity with administration of the flu 
vaccine in college students and the presence of a correlation from these findings.  The principal 
investigators will be responsible for the retrieval of the data from the Qualtrics system at the 
conclusion of the survey period.  The data retrieved will be analyzed to determine possible trends 
that point at the possibility of a correlation.  It is estimated date for the investigators to complete 
this study and analyze the results is the end of February of 2018; however, the data will be stored 
under password protection until Spring of 2021.  Participants will be provided contact 
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information of the principal investigators and will be free to contact them for any information 
regarding the study. 
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CHAPTER FOUR: RESULTS 
Sample Demographics 
As the survey was widely distributed through online collaborative websites as well as 
flyers around campus, containing a QR code with the link to the survey that can be scanned 
through the camera of any smart phone device, it was easily accessible by students of all years 
and majors; thus, allowing for a simple random sample that is representative of the population to 
be obtained. The online survey was active for six weeks in which 117 responses were received 
from a wide range of undergraduate students studying at the University of Central Florida. The 
study sample participants consisted of students ranging from 18 to 34 years of age with a high 
skew of female participants at 78.6% (n=92) and only 21.4% males (n=25). A huge majority of 
the participants reported to be White at 67.5% (n=79), followed by Hispanics and Latinos, 
African-Americans, and Asians. Roughly half of the participants represented science majors, 
which included Health Sciences Pre-Clinical, Biomedical Sciences and Biology, representing a 
combined majority of 47.8% (n=56). Other majors, such as Psychology, Finance, and Forensic 
Science, represented the remaining sample participants 52.2% (n=61). Additionally, a great 
amount of the sample represented upperclassmen including juniors, seniors and super-seniors at 
74.3% (n=87); of which juniors comprised 60% (n=52). The Freshman class was the most 
underrepresented in the population with only six participants, which could likely be a result of 
selection bias as discussed in the methodological limitations section. 
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Sample Participants and Side Effects Resulting from the Flu Shot 
Only 86 of the 117 (73.5%) reported ever receiving the flu shot in their lives, but only 37 
of these participants received the flu shot in the past six months; figure 1. To understand the 
efficacy of the flu vaccine for the 2017-2018 flu season, only participants who received the flu 
shot in the past six months, which are 37 responses, will be used in the data analysis process as 
the baseline for comparison. Of those who received the flu shot in the past six months, only 27% 
(n=10) suffered from a side effect of any kind. Side effects were divided into two categories; one 
being flu-like symptoms and the other being orally-related side effects which are associated with 
the mouth. All 10 participants that reported suffering from side effects following receiving the 
flu shot, suffered from flu-like symptoms; however, only three of them suffered orally-related 
symptoms simultaneously; figure 2. 
Figure 1: Percentage of Students that Received the Flu Shot within the Past Six Months 
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Figure 2: Percentage of Students Experiencing Side Effects 
 
 
 The details of the symptoms experienced by the sampled population was also reported; 
however, question regarding the specific side effects suffered by the participants were limited by 
the survey system to students who answered previous questions that classified them as sufferers 
of the flu vaccine. A list of common flu-like and orally-related symptoms that could occur as a 
result of having the influenza virus were listed for participants to choose the ones they 
experienced within three weeks of receiving the vaccine. Only three oral cavity manifested side 
effects were reported, which were swelling of the lips, ulcers, and the presence of white spots in 
the mouth. On the other hand, seven different flu-like side effects were reported; three dealt with 
pain of the upper arm, whether it being soreness, redness, or swelling, and the other four were 
headache, dizziness, weakness, and fever. Table 1 and figure 3 represent the breakdown and 
frequency of occurrence of each side effect as experienced by the participants in the sample 
population.  
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Table 1: Symptoms Experienced by Sample 
Symptom	 Symptom	Type		 Frequency	 Percentage	
Swelling	of	the	lips	 Orally-related	 2	 9%	
Ulcers	 Orally-related	 2	 9%	
White	spots	in	mouth	 Orally-related	 1	 4.5%	
Weakness	 Flu-like	 3	 13.6%	
Dizziness	 Flu-like	 2	 9%	
Soreness	of	upper	arm	 Flu-like	 5	 22.7%	
Headache	 Flu-like	 2	 9%	
Fever	 Flu-like	 2	 9%	
Swelling	of	upper	arm	 Flu-like	 2	 9%	
Redness	of	upper	arm	 Flu-like	 1	 4.5%	
 
Figure 3: Frequency of Symptoms Suffered by Flu Shot Receivers in 2017 
 
Symptom Characteristics 
Moreover, participants were asked to report the particular characteristics associated with 
the side effects experienced. These duration that the symptoms lasted for ranged from a day to 
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effects. The severity of the symptoms was also expressed by the participants as pain levels 
ranging from mild to unbearable using a Likert scale where 1 represented mild, or light, pain and 
5 represented severely unbearable pain. A pain of level 3 was average severe. According to the 
reported results, 40% (n=4) of participants suffered from a level 2 pain, which was equivalent to 
moderate pain. The remaining 60% was divided evenly over a level 1, 3, and 5 pain with 20% 
reported for each category. Participants were also asked to identify seeking medical attention as a 
result of the severity of the symptoms experienced. Medical attention was defined as visiting the 
individual’s primary care physician, going into the emergency department, or a local walk-in 
clinic. Only 30% (n=3) of those who suffered from side effects needed medical attention for their 
symptoms and 66.6% (n=2) of them had reported a pain level of 5 showing severely unbearable 
pain; table 2. 
Table 2: Duration and Severity of Side Effects 
Number	of	
Orally-related	
symptoms	
Number	of	flu-
like	symptoms	
Duration	of	
symptoms	
Severity	of	
Symptoms	
Medical	
Attention	
Needed	
1	 3	 3	days	 2-moderate	 No	
1	 1	 Over	a	week	 5-unberable	 Yes	
0	 1	 3	days	 1-mild	 No	
0	 4	 5	days	 3-severe	 Yes	
0	 1	 1	day	 1-mild	 No	
0	 1	 3	days	 2-moderate	 No	
0	 4	 3	days	 2-moderate	 no	
0	 2	 1	day	 3-severe	 No	
1	 1	 Over	a	week	 5-unberable	 Yes	
0	 2	 3	days	 2-moderate	 No	
 In addition to studying the details of the side effects reported by participants in the 
sample, the relationship between demographics and symptom rate was also explored. To quantify 
the symptoms, 1 point was awarded for each flu-like symptom and 2 points were awarded for 
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each orally-related side effect reported for a maximum number of 7 points in the symptom rate. 
The age of the participants who received the flu shot within the past six months (n=37) was 
compared to the symptom rate reported. Participants who did not suffer from any side effects 
(n=27) were awarded zero points. A scatter plot was created, figure 4, to show the results and a 
line of best fit was inserted to determine the r-squared value and correlational value for the 
results. The R-squared value, or coefficient of determination, is a statistical measure of how 
close the data are to the regression line. For the line of best fit inserted into the scatter plot of age 
versus symptom rate, the R-squared value was 0.02971, which indicates that the model is a weak 
indication of the variability of the response data around the mean. The correlation coefficient, R-
value, was calculated to be -0.3116, which shows a weak negative linear relationship and thus a 
week correlation between age and symptom rate, where younger participants reported more 
symptoms. Gender was another factor that was also compared to the symptom rate. A two-
sample Z-test was used to compare the symptom rate average of male and female participants, 
which was calculated to be 0.33 for males and 0.84 for females. Using a 5% significance level to 
determine if the proportions are the same, a Z-Score of 2.641 and p-value of 0.0083 were 
calculated. This indicates a calculate probability of 0.8% for the averages of symptom rates for 
males and females to happen randomly or by chance. A p-value that is less than 5%, as in this 
case, shows a statistically significant result and allows for the rejection of the null hypothesis 
stating that the proportions for males and females are the same, but rather that they signify the 
appearance of a correlation between gender and symptom rate, where females are significantly 
more affected than males. 
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Figure 4: Symptom Rate and Age in Sample 
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CHAPTER FIVE: DISCUSSION 
Patterns of Vaccination  
So far, this appears to be the first study to examine the effects of the flu vaccine on the 
oral cavity. Our research was aimed at exploring the presence of trends associated with 
symptoms experienced with receiving the flu shot for the 2017-2018 flu season. The target 
population of undergraduate students at a large college campus should serve as a baseline for 
generalization of the results due to the huge age range included in the sample from late teens to 
mid-thirties (18-34). It can be inferred from the survey responses that between July and 
December of 2017, which is the peak of the influenza infection season, only 31.6% of the student 
body had received an immune protection against this virus in the form of the flu shot; not taking 
into account other methods of virus protection such as the nasal flu mist vaccination. Even 
though the vaccine is highly recommended yearly for individuals over the age of 6 months and is 
offered at discounted prices and even for free at the university, many people refuse be vaccinated 
due to a fear or misunderstanding concerning the flu vaccine. They believe that the cost 
outweighs the benefit in that the flu shot causes the individual to be sick with the virus. This is a 
misconception, however, as the flu-like symptoms that happen following receiving the 
vaccination are common side effects that take place as part of the body’s normal immune 
response to the foreign inoculated influenza virus that had just entered. In most cases, the side 
effects occurring after receiving the vaccine are far less severe than the symptoms caused by 
actual flu illness [2]. 
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Factors Affecting Symptom Rate 
 In looking at different factors associated with reporting side effects experienced after 
receiving the flu shot, it was determined that age and gender played a role in this process. 
Although a week correlational coefficient of R=-0.3116 was calculated, it can still be concluded 
that the younger range of the population reported suffering from far more symptoms than the 
older participants in the study. This could be due to the fact that teenagers are in the developing 
process of their immune system, while those who are in their twenties are at the peak of B and T 
cell production from the thymus and bone marrow leading to a better immune response [16]. 
Stress could also be a factor that affects the levels to which the symptoms are manifested and the 
significant toll they have on an individual.  
Gender was also an element in the overall results of the survey. A significantly greater 
number of females participated in the survey than males which is expected since the university 
student body is comprised of 55.1% females and only 44.9% males. 37 participants stated that 
they had received the flu shot in the past six months; only six of them were males. This shows 
that females tend to be more vigilant with their health. Of the ten participants that reported 
suffering side effects, only one of them was male and his symptom rate score was 2. This is 
likely due to the fact that females are more likely to report symptoms than males and that they 
usually have lower tolerance for pain. Due to the fact that the severity of the symptoms 
experienced by the participants were asked to be self-reported according to a Likert scale, the 
subjective nature to pain tolerance could have led to more females selecting a level 5, unbearable 
pain, when describing the harshness of the side effects experienced. The three participants that 
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reported getting medical attention for their symptoms were also females. Females were also the 
ones to report finding a manifestation related to their oral cavity. 
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CHAPTER SIX: METHODOLOGICAL LIMITATIONS 
 The result of this study should be considered in the context of a number of limitations. 
Selection bias, sample size, subjectivity, and population representation are among the 
considerations that should be revised when replicating this study. 
 For this study, the sample size of 117 may have not been large enough to obtain useful 
data as only 37 of the survey responses were considered for the data analysis while the other 80 
were disregarded as they had not received the flu shot in the past six months, which is the time 
period being examined by the researchers. The relatively small sample size could have been 
caused by limitations of having an online survey to collect information. Even though the survey 
was widely distributed through online collaborative websites as announcements on different 
UCF affiliated pages on Facebook as well as in the classes taught by the principal investigator on 
the Webcourses page of the course, not all students studying at the university had access to these 
online links. Efforts were also made to post flyers around campus, containing a QR code with the 
link to the survey that can be scanned through the camera of any smart phone device, however, 
not all students are aware of the ability to scan QR codes through a cellphone camera. 
Selection bias was also apparent when considering the large number of juniors that 
responded to the survey, which comprised 44.4% of the total survey responses. Even though the 
survey was to be easily accessible by students of all years and majors, it seems that the majority 
of students that were part of the Facebook pages where the survey link was posted were juniors. 
This is mainly due to the fact that many students were recruited to take the survey from the 
researcher’s classes and these classes have primarily upperclassmen causing the presence of a 
		
21	
selection bias in the sample and skewing the average age and grade level of students. Moreover, 
the effects of the flu shot on the oral cavity in non-college students including children and the 
elderly was not investigated in this study and might add significance to the results obtained.  
The online survey also led to the presence of limitations in the results. Participants were 
asked to self-report symptoms suffered within three weeks of receiving the flu shot which they 
could have been vaccinated with up to six months earlier from when the survey was posted. This 
could have led to inaccuracy in the answers given in the survey as it is purely based on the 
memory of the participants. Another limitation could be the list of symptoms given in the survey 
questions for participants to select from. Although more than one answer choice can be selected 
for the questions asking about symptoms and the symptom list consists of most occurring side 
effects caused by the flu shot, the participant might have suffered more side effects than the ones 
listed. The subjectivity of the pain levels as reported by the Likert scale could have also added to 
the limitations of the results. 
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CHAPTER SEVEN: CONCLUSION 
One of the major questions that this study hoped to answer was whether or not a 
relationship existed between receiving the flu shot and suffering from orally-related side effects. 
After qualitative analysis of the survey results, it appears that there are no statistically significant 
relationships amongst these variables. Rather the data shows that the vaccine effectiveness for 
the 2017-2018 flu season was high against influenza A and influenza B and that the benefits of 
being vaccinated against the virus outweigh the cost. Unlike some vaccinations, including 
diphtheria, tetanus, acellular pertussis, and polio vaccinations, the influenza vaccine proved to 
have no association with periodontal disease or dental carries. Only ulcers, white spots on the 
lips, and swelling of the lips were observed with correspondence to the oral cavity, which are 
common side effects associated with fighting infections. 
The flu vaccine is for the most part manufactured from inactivated forms of the most 
prevailing strains of the virus or ones that are evolved from previous influenza seasons. The 
human body naturally reacts against any foreign invaders which explains the side effects 
experienced by individuals who choose to take the flu shot. The shot, however, does not protect 
against virus strains not covered by the vaccine or against flu-like symptomatic conditions 
caused by several other diseases including common allergies. The eradication of side effects 
from occurring completely is, up till this point, beyond medical and scientific as the human 
system is more intelligent. For this reason, people who have severe allergies or previously 
experienced unbearable pain from the flu shot vaccine are advised not to take it and refer to other 
preventive measures against the virus. 
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Although no substantial relationships were observed between receiving the flu shot and 
orally-related symptoms, other interesting trends were interpreted from the data. There appeared 
to be a correlation between gender and reporting of symptoms as it was significantly higher for 
females. The results also showed that 80% of the symptoms reported by survey participants dealt 
with pain in the upper arm encompassing swelling, redness, and soreness of the upper arm. This 
inflammatory response occurs at the injection site and is caused by the needle and the 
administered serum which is being fought against by the body’s immune system. Future work 
may be expanded beyond this to allow the study of the effects of the flu vaccine on the oral 
cavity based on screening rather than an online survey. This would allow for more accurate data 
collection and validation.  
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